Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2012
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2491040C Thrombin-cleavable factor x analogues
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
04/2012
04/26/2012WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012WO2012054530A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054528A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054527A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012051692A1 Processes for the preparation of rivaroxaban and intermediates thereof
04/26/2012WO2011153513A3 Nanoemulsion composition containing vitamin k
04/26/2012US20120101169 Methods of providing anticoagulation effects in subjects
04/26/2012US20120101167 Treatment of ocular and cerebral ischemia
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101129 Methylphenidate Derivatives and Uses of Them
04/26/2012US20120101123 Compounds
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101068 Diphenyl sulfide derivatives and medicines containing same as active ingredient
04/26/2012US20120101067 Methods for enhancing hematopoietic progenitor cell engraftment
04/26/2012US20120101052 15-thia steroid compounds and compositions
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101006 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
04/26/2012US20120100208 Stable pharmaceutical composition and methods of using same
04/26/2012US20120100200 System And Method For Satellite Drug Delivery
04/26/2012US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy
04/26/2012US20120100148 Anti-ferroportin 1 monoclonal antibodies and uses thereof
04/26/2012US20120100139 CD86 Antagonist Multi-Target Binding Proteins
04/26/2012CA2815063A1 Processes for the preparation of rivaroxaban and intermediates thereof
04/25/2012EP2444492A1 Chicken-derived anti-lox-1 antibody
04/25/2012EP2444402A1 Compound having spiro-bonded cyclic group and use thereof
04/25/2012EP2444087A1 Pharmaceutical composition having improved solubility
04/25/2012EP2443124A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
04/25/2012EP2442837A1 Bone marrow extracellular matrix extract and therapeutic use thereof
04/25/2012EP2442830A2 Hemostatic material and delivery device
04/25/2012EP2442822A2 Peptide therapy for increasing platelet levels
04/25/2012EP2442791A1 Dosage forms of apixaban
04/25/2012EP2307354B1 Process for preparing a benzoylbenzeneacetamide derivative
04/25/2012CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor
04/25/2012CN102427852A Compositions and methods for inhibiting expression of glucocorticoid receptor (GCR) genes
04/25/2012CN102427806A Transdermal pharmaceutical preparation and administration of tirofiban
04/25/2012CN102423485A 含有醋酸去氨加压素的口服组合物及其制备方法 Desmopressin acetate oral composition and preparation method comprising
04/25/2012CN102423425A 清肝活血丹 Liver in medicinal
04/25/2012CN102423368A Chinese medicinal composition for treating sequelae of cerebral thrombosis and cerebral hemorrhage, as well as preparation method thereof
04/25/2012CN102423330A 一种滇桂艾纳香片及其制备工艺 One kind of Yunnan and Guangxi Ena Jasmine and preparation process
04/25/2012CN102423329A 一种三七总皂苷提取液的脱色方法 Decolorization method of total saponin extract of Panax
04/25/2012CN102423303A Tirofiban hydrochloride lyophilization powder injection
04/25/2012CN102048905B 一种补气养血美颜口服液及其制备工艺 One kind of qi and blood beauty oral and preparation process
04/25/2012CN102018839B 克栓益寿药酒 G bolt longevity wine
04/25/2012CN101966293B 止血药物 Hemostatic agents
04/25/2012CN101891747B Compound capable of inhibiting phosphodiesterase type 5 and preparation method
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101810612B 荜拔酰胺类化合物抗血小板聚集的用途 Long pepper amides use of anti-platelet aggregation
04/25/2012CN101708204B 一种治疗心脑血管病的药物组合物 A method of treating cardiovascular diseases pharmaceutical composition
04/25/2012CN101564463B 一种治疗功血的药物 A method of treating drug DUB
04/25/2012CN101475577B 氯吡格雷硫酸复盐化合物及其制备方法 Clopidogrel sulfate double salt compounds and methods
04/25/2012CN101376676B 聚乙二醇化红细胞生成素蛋白长效制剂 PEGylated erythropoietin protein drug depot
04/25/2012CN101361717B 巴曲酶冻干粉针制剂及其制备方法 Batroxobin freeze-dried powder and its preparation method
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163734 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
04/24/2012US8163536 Apparatus for use in the propagation of pluripotent cells
04/24/2012CA2671383C Dried composition
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/19/2012WO2012051339A2 Methods and compositions for treating respiratory conditions using platelet enriched plasma
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012004416A3 Treatment of a disease associated with retinal degenerative disorder
04/19/2012WO2011163533A4 One step removal of selected molecules from body fluid and tissue
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095091 Antiepileptic, hypocholesterolemic and neuroprotective compound
04/19/2012US20120095089 Schweinfurthins and uses thereof
04/19/2012US20120095085 Nucleic acid modulators of clec-2
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095063 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095052 Par-1 antagonism in fed or antacid-dosed patients
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095044 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
04/19/2012US20120095035 Crystals of prasugrel hydrobromate
04/19/2012US20120095032 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
04/19/2012US20120095019 Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095001 Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094942 Chemosensory Receptor Ligand-Based Therapies
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094907 Peptide therapy for increasing platelet levels
04/19/2012US20120094906 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120093948 Nitric Oxide Treatments
04/19/2012US20120093943 Pharmaceutically active compounds, their manufacture, compositions containing them, and their use
04/19/2012US20120093927 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
04/19/2012US20120093898 Metal Ion Nanoclusters
04/19/2012US20120093891 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120093888 micro-emulsions for the treatment of rheumatic disorders
04/19/2012US20120093885 Therapeutic vesicles
04/19/2012US20120093840 Targeted delivery of factor viii proteins to platelets
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 671